Filter Results:
- Full text PDF available (29)
Publication Year
1979
2018
- This year (9)
- Last 5 years (38)
- Last 10 years (66)
Publication Type
Co-author
Journals and Conferences
Cell Type
Learn More
- Gero Hütter, D. A. Nowak, +10 authors Eckhard Thiel
- The New England journal of medicine
- 2009
Infection with the human immunodeficiency virus type 1 (HIV-1) requires the presence of a CD4 receptor and a chemokine receptor, principally chemokine receptor 5 (CCR5). Homozygosity for a 32-bp… (More)
- Pieter Sonneveld, Ingo G. H. Schmidt-Wolf, +25 authors Hartmut Goldschmidt
- Journal of clinical oncology : official journal…
- 2012
PURPOSE
We investigated whether bortezomib during induction and maintenance improves survival in newly diagnosed multiple myeloma (MM).
PATIENTS AND METHODS
In all, 827 eligible patients with newly… (More)
- Ulrich Keilholz, Anne Letsch, +7 authors Carmen Scheibenbogen
- Blood
- 2009
This study investigated the immunogenicity of Wilms tumor gene product 1 (WT1)-peptide vaccination in WT1-expressing acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients without… (More)
- Olga Blau, Wolf-Karsten Hofmann, +5 authors Igor Wolfgang Blau
- Experimental hematology
- 2007
OBJECTIVE
Bone marrow mesenchymal stroma cells (BMSC) are key components of the hematopoietic microenvironment. The question of whether BMSC from patients with hematological disorders have… (More)
- Olga Blau, Claudia Dorothea Baldus, +12 authors Igor Wolfgang Blau
- Blood
- 2011
Mesenchymal stromal cells (MSCs) are an essential cell type of the hematopoietic microenvironment. Concerns have been raised about the possibility that MSCs undergo malignant transformation. Several… (More)
- Martin Schmidt-Hieber, Julie Schwender, +10 authors Igor Wolfgang Blau
- Haematologica
- 2011
BACKGROUND
Limited data are available on characteristics of viral encephalitis in patients after allogeneic stem cell transplantation.
DESIGN AND METHODS
We analyzed 2,628 patients after allogeneic… (More)
- Maria Teresa Petrucci, Pilar Giraldo, +9 authors Joan Bladé
- British journal of haematology
- 2013
Multiple myeloma (MM) typically follows a relapsing course with many patients requiring multiple therapies. This single-arm phase 2 study prospectively evaluated the efficacy and safety of bortezomib… (More)
- Jared Casper, Jerzy Holowiecki, +19 authors Dietrich W Beelen
- Bone Marrow Transplantation
- 2012
An alternative reduced-toxicity conditioning regimen for allogeneic transplantation, based on treosulfan and fludarabine, has recently been identified. The safety and efficacy of this new… (More)
- Kai Neben, Henk M. Lokhorst, +22 authors Hartmut Goldschmidt
- Blood
- 2012
In patients with multiple myeloma (MM), risk stratification by chromosomal abnormalities may enable a more rational selection of therapeutic approaches. In the present study, we analyzed the… (More)
- Martin Schmidt-Hieber, Thomas Fietz, +4 authors Igor Wolfgang Blau
- British journal of haematology
- 2005
Acute graft-versus-host disease (aGVHD) occurs in up to 80% of patients who undergo allogeneic stem cell transplantation (SCT) and contributes significantly to transplant-related mortality (TRM). We… (More)